Clinical Trials on Influenza Like Illness in Poland

Total 375 results

Emergo Therapeutics, Inc.

Completed

Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

Influenza -Like Illness

United States
GlaxoSmithKline

Completed

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b | Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine

Poland, United Kingdom
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Influenza

Poland
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Ology Bioservices

Completed

Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004

Influenza

Poland
Novartis
Novartis Vaccines

Completed

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Influenza

Poland
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Pandemic H5N1 Influenza

Poland, Turkey
Medical University of Warsaw

Unknown

Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw

Vaccnation in HCW

Poland
Uniwersytecki Szpital Kliniczny w Opolu

Completed

An Infraclavicular Landmark-based Approach to the Axillary Vein

Critical Illness

Poland
Wroclaw Medical University

Unknown

Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers

Influenza | Vaccination | Attitude of Health Personnel

Poland
Uniwersytecki Szpital Kliniczny w Opolu

Completed

Ultrasound-guided Axillary Artery vs Femoral Artery Cannulation. (AxFemArt)

Critical Illness

Poland
Uniwersytecki Szpital Kliniczny w Opolu

Completed

Ultrasound-guided Catheterization of the Axillary Vein

Critical Illness

Poland
Centre of Postgraduate Medical Education

Unknown

Different Regimens in Influenza Postexposure Chemoprophylaxis in Children

Influenza | Prevention | Exposure

Poland
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States, Australia, Mexico
Medical University of Silesia

Recruiting

Vasopressor Support, Mean Arterial Pressure and Capillary Refill Time in Critically Ill Patients

Critical Illness

Poland
BiondVax Pharmaceuticals ltd.

Completed

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

Influenza

Poland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
Uniwersytecki Szpital Kliniczny w Opolu

Completed

Ultrasound Guided Axillary Versus Jugular Central Venous Catheterization

Critical Illness

Poland
Uniwersytecki Szpital Kliniczny w Opolu

Withdrawn

Ultrasound Assessment of Changes in the Diameter of the Common Carotid Artery After Increasing the Preload of the Heart

Critical Illness | Fluid Responsiveness

Poland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
VA Office of Research and Development

Not yet recruiting

Home-based Exercise for SMI

Serious Mental Illness

United States
Medical University of Gdansk

Completed

Volume Responsiveness Assesment After Propofol.

Critical Illness | Circulatory Failure | Fluid Volume Disorder

Poland
Medical University of Lublin

Unknown

Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients

Critical Illness | Septic Shock | Antibiotic Resistant Infection

Poland
Institute of Cardiology, Warsaw, Poland
Solvay Pharmaceuticals

Completed

Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

Coronary Artery Disease

Poland
Fresenius Kabi

Terminated

Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness

Critical Illness

France, Germany, Poland
Medical University of Gdansk

Completed

Serum Free Amino Acid Concentrations in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy (CRRT)

Sepsis | Amino Acid Catabolism Disorder

Poland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. (FluMist)

Influenza

Belgium, Poland, United Kingdom
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Influenza

Austria, Germany, Poland
Medical University of Gdansk

Recruiting

Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients

Critical Illness | Thrombosis

Poland
Wroclaw Medical University

Recruiting

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis. (VACCINE-CHF)

Heart Failure | Influenza | RSV Infection | Vaccines

Poland
Medical University of Gdansk

Completed

Nebulized Bronchodilators and Cardiac Repolarization

Influence of Nebulized Bronchodilatators on Selected | Electrophysiological Parameters

Poland
FluGen Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Influenza Vaccine

United States
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

Healthy Networks Water Treatment Study (HNWT)

Household Water Treatment | Waterborne Illness

Kenya
Uniwersytecki Szpital Kliniczny w Opolu

Recruiting

Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT (NephroD)

Vitamin D3 Deficiency

Poland
Medical University of Warsaw

Active, not recruiting

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Obesity | Vaccine Adverse Reaction | Vaccine Reaction | Influenza | Tolerance | Pregnancy; Infection | Elderly Infection

Poland
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Healthy Volunteers | Influenza Immunization

France, Belgium, Germany, Italy, Netherlands, Poland
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects

Prophylaxis: Influenza

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly

Influenza

Poland
GlaxoSmithKline

Completed

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

Poland, United Kingdom
Erasmus Medical Center

Not yet recruiting

Perceptions and Experiences of (Family Members of) People With Mental Illness About the Chance for Mental Illness in (Future) Children, and Needs for Care and Research (PANDAcc)

Mental Illness

Netherlands
IQuum, Inc.
Roche Molecular Systems, Inc

Completed

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
ModernaTX, Inc.

Completed

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Seasonal Influenza

United States
Ology Bioservices

Completed

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Influenza | Pandemic Influenza

United States
Centers for Disease Control and Prevention
Kaiser Permanente; Baylor Scott and White Health; Abt Associates

Completed

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Influenza

United States
Leiden University Medical Center
Erasmus Medical Center

Completed

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

HIV

Netherlands
MedImmune LLC
AstraZeneca

Completed

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season (FluMist)

Healthy | Influenza

United States
Medical University of Gdansk
Baxter Healthcare Corporation

Unknown

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis

Poland
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Influenza Immunization

Puerto Rico, United States
Seqirus

Completed

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Influenza

United States
Amsterdam UMC, location VUmc

Unknown

Administrative Workload in the Intensive Care Unit (AWIC)

Critical Illness

Netherlands

Clinical Trials on Influenza Like Illness in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations